Earnings Feed
Start Free
FULLER H B CO·4

May 26, 3:50 PM ET

Corkrean John J 4

4 · FULLER H B CO · Filed May 26, 2026

Research Summary

AI-generated summary of this filing

Updated

FULLER H B CO (FUL) CFO John J. Corkrean Receives Award

What Happened

  • John J. Corkrean, Executive Vice President and Chief Financial Officer of Fuller H B Co (FUL), was granted 218.13 units (reported as a derivative acquisition) on 2026-05-22. The filing reports a per-unit value of $57.78, for a total reported value of $12,604. This was an award/grant (code A), not a market purchase or sale.

Key Details

  • Transaction date: 2026-05-22; filing date: 2026-05-26 (Form 4).
  • Price/value: $57.78 per unit; total value reported $12,604.
  • Quantity: 218.13 units acquired (reported as derivative securities that convert into common stock).
  • Shares owned after transaction: not disclosed in the summary provided here — see the full Form 4 for post-transaction holdings.
  • Footnotes: The filing includes footnotes indicating these units convert 1-for-1 into common shares, may include dividend-equivalent features, and may be subject to vesting, deferral, or holding-period rules. Review the specific footnote numbers on the Form 4 for exact terms.
  • Timeliness: The Form 4 was filed within the typical 2-business-day reporting window and appears timely.

Context

  • This transaction is an award/grant of units (derivative securities) rather than an open-market purchase or sale. Such grants are commonly part of executive compensation (restricted stock units/stock units or deferred compensation) and often vest or convert into shares over time — they do not necessarily indicate immediate buying or selling of stock. For precise vesting, conversion, or deferral conditions, consult the full Form 4 and its footnotes.

Insider Transaction Report

Form 4
Period: 2026-05-22
FULLER H B COFUL
Corkrean John J
Executive VP and CFO
Transactions
  • Award

    Phantom Units

    [F1][F2][F3]
    2026-05-22$57.78/sh+218.13$12,604→ 34,017.27 total
    Exercise: $0.00→ Common Stock (218.13 underlying)
Holdings

  • Common Stock

    59,508

  • Employee Stock Option (Right-to-Buy)

    [F4]
    Exercise: $45.05From: 2020-01-24Exp: 2029-01-24→ Common Stock (41,208 underlying)
    41,208

  • Employee Stock Option (Right-to-Buy)

    [F4]
    Exercise: $48.35From: 2021-01-24Exp: 2030-01-24→ Common Stock (48,309 underlying)
    48,309

  • Employee Stock Option (Right-to-Buy)

    [F4]
    Exercise: $50.10From: 2018-01-26Exp: 2027-01-26→ Common Stock (23,696 underlying)
    23,696

  • Employee Stock Option (Right-to-Buy)

    [F4]
    Exercise: $51.89From: 2022-01-27Exp: 2031-01-27→ Common Stock (38,376 underlying)
    38,376

  • Employee Stock Option (Right-to-Buy)

    [F4]
    Exercise: $53.57From: 2019-01-25Exp: 2028-01-25→ Common Stock (21,834 underlying)
    21,834

  • Employee Stock Option (Right-to-Buy)

    [F5]
    Exercise: $59.81From: 2027-01-26Exp: 2036-01-26→ Common Stock (39,347 underlying)
    39,347

  • Employee Stock Option (Right-to-Buy)

    [F5]
    Exercise: $64.28From: 2026-01-27Exp: 2035-01-27→ Common Stock (24,570 underlying)
    24,570

  • Employee Stock Option (Right-to-Buy)

    [F4]
    Exercise: $68.17From: 2024-01-24Exp: 2033-01-24→ Common Stock (22,312 underlying)
    22,312

  • Employee Stock Option (Right-to-Buy)

    [F4]
    Exercise: $72.94From: 2023-01-24Exp: 2032-01-24→ Common Stock (21,997 underlying)
    21,997

  • Employee Stock Option (Right-to-Buy)

    [F5]
    Exercise: $77.72From: 2025-01-26Exp: 2034-01-26→ Common Stock (24,774 underlying)
    24,774

  • Restricted Stock Units

    [F6][F7][F8]
    Exercise: $0.00From: 2025-01-26Exp: 2027-01-26→ Common Stock (1,459.82 underlying)
    1,459.82

  • Restricted Stock Units

    [F6][F7][F8]
    Exercise: $0.00From: 2027-01-26Exp: 2029-01-26→ Common Stock (5,848.8 underlying)
    5,848.8

  • Restricted Stock Units

    [F6][F7][F8]
    Exercise: $0.00From: 2026-01-27Exp: 2028-01-27→ Common Stock (2,952.19 underlying)
    2,952.19
Footnotes (8)
  • [F1]These units (acquired after 12-31-04) convert into shares of common stock on a 1-for-1 basis.
  • [F2]These units (acquired after 12-31-04) convert into shares of common stock upon the earlier of certain termination events as specified in the Key Employee Deferred Compensation Plan or such earlier date as selected by the participant, subject to holding periods required by law.
  • [F3]Amount includes stock units acquired pursuant to a dividend equivalent feature.
  • [F4]This option is 100% vested.
  • [F5]This option vests in three annual installments (33%, 33%, and 34%) beginning on the date shown.
  • [F6]These restricted stock units convert into shares of common stock on a 1-for-1 basis.
  • [F7]These restricted stock units vest in three annual installments (33%, 33%, and 34%) beginning on the date shown.
  • [F8]Amount includes restricted stock units acquired pursuant to a dividend equivalent reinvestment feature.
Signature
/s/ Patrick J. Seul, Attorney-in-Fact|2026-05-26

Documents

1 file
  • 4
    doc4.xmlPrimary